168 related articles for article (PubMed ID: 29535823)
1. Overexpression of p54
Yamamoto R; Osawa T; Sasaki Y; Yamamoto S; Anai M; Izumi K; Matsumura Y; Sakai J; Aburatani H; Mizokami A; Kodama T; Tanaka T
Oncotarget; 2018 Feb; 9(12):10510-10524. PubMed ID: 29535823
[TBL] [Abstract][Full Text] [Related]
2. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
Lu JY; Sewer MB
Mol Cell Biol; 2015 Apr; 35(7):1223-37. PubMed ID: 25605330
[TBL] [Abstract][Full Text] [Related]
3. Structure, Dynamics, and Interaction of p54(nrb)/NonO RRM1 with 5' Splice Site RNA Sequence.
Duvignaud JB; Bédard M; Nagata T; Muto Y; Yokoyama S; Gagné SM; Vincent M
Biochemistry; 2016 May; 55(18):2553-66. PubMed ID: 27064654
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription.
Sewer MB; Nguyen VQ; Huang CJ; Tucker PW; Kagawa N; Waterman MR
Endocrinology; 2002 Apr; 143(4):1280-90. PubMed ID: 11897684
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of P54(nrb) /NonO correlates with collagen deposition and fibrosis in human aortic dissection.
Ren Z; Wang Z; Hu Z; Hu X; Zhang H; Wu H; Hu R; Liu H
Histopathology; 2014 Oct; 65(4):570-80. PubMed ID: 24720418
[TBL] [Abstract][Full Text] [Related]
6. p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A.
Zhu Z; Zhao X; Zhao L; Yang H; Liu L; Li J; Wu J; Yang F; Huang G; Liu J
Oncogene; 2016 Mar; 35(11):1399-410. PubMed ID: 26148231
[TBL] [Abstract][Full Text] [Related]
7. Splicing Regulator p54
Hu Z; Dong L; Li S; Li Z; Qiao Y; Li Y; Ding J; Chen Z; Wu Y; Wang Z; Huang S; Gao Q; Zhao Y; He X
Hepatology; 2020 Aug; 72(2):548-568. PubMed ID: 31815296
[TBL] [Abstract][Full Text] [Related]
8. Regulation of PCGEM1 by p54/nrb in prostate cancer.
Ho TT; Huang J; Zhou N; Zhang Z; Koirala P; Zhou X; Wu F; Ding X; Mo YY
Sci Rep; 2016 Sep; 6():34529. PubMed ID: 27682980
[TBL] [Abstract][Full Text] [Related]
9. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
10. PSF and p54(nrb)/NonO--multi-functional nuclear proteins.
Shav-Tal Y; Zipori D
FEBS Lett; 2002 Nov; 531(2):109-14. PubMed ID: 12417296
[TBL] [Abstract][Full Text] [Related]
11. NONO and tumorigenesis: More than splicing.
Feng P; Li L; Deng T; Liu Y; Ling N; Qiu S; Zhang L; Peng B; Xiong W; Cao L; Zhang L; Ye M
J Cell Mol Med; 2020 Apr; 24(8):4368-4376. PubMed ID: 32168434
[TBL] [Abstract][Full Text] [Related]
12. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
Ito T; Watanabe H; Yamamichi N; Kondo S; Tando T; Haraguchi T; Mizutani T; Sakurai K; Fujita S; Izumi T; Isobe T; Iba H
Biochem J; 2008 Apr; 411(1):201-9. PubMed ID: 18042045
[TBL] [Abstract][Full Text] [Related]
13. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S
Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770
[TBL] [Abstract][Full Text] [Related]
14. A crystallographic study of human NONO (p54(nrb)): overcoming pathological problems with purification, data collection and noncrystallographic symmetry.
Knott GJ; Panjikar S; Thorn A; Fox AH; Conte MR; Lee M; Bond CS
Acta Crystallogr D Struct Biol; 2016 Jun; 72(Pt 6):761-9. PubMed ID: 27303796
[TBL] [Abstract][Full Text] [Related]
15. The transcription-splicing protein NonO/p54nrb and three NonO-interacting proteins bind to distal enhancer region and augment rhodopsin expression.
Yadav SP; Hao H; Yang HJ; Kautzmann MA; Brooks M; Nellissery J; Klocke B; Seifert M; Swaroop A
Hum Mol Genet; 2014 Apr; 23(8):2132-44. PubMed ID: 24301678
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
Ding G; Wang J; Feng C; Jiang H; Xu J; Ding Q
Oncotarget; 2016 Sep; 7(39):64309-64317. PubMed ID: 27602760
[TBL] [Abstract][Full Text] [Related]
17. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
[TBL] [Abstract][Full Text] [Related]
18. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
19. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
[No Abstract] [Full Text] [Related]
20. Nuclear scaffold protein p54
Shen M; Zhang R; Jia W; Zhu Z; Zhao X; Zhao L; Huang G; Liu J
Oncogene; 2021 Jun; 40(24):4167-4183. PubMed ID: 34079086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
